Cancer stem cells in relation to treatment

Norikatsu Miyoshi, Tsunekazu Mizushima, Yuichiro Doki, Masaki Mori

研究成果: ジャーナルへの寄稿評論記事

抜粋

The classical cancer therapies, including chemotherapy and radiation therapy, can initially show good results and tumor shrinkage; however, for most cancer patients disease recurrence is a common event. This tumor regrowth following therapy is now thought to depend on a small population of cancer stem cells (CSCs), which, similar to other stem cells, have the capacity for self-renewal and multipotent differentiation. Cancer stem cells have been identified based on cell surface protein expression in many tumor types, and for all diseases studied, this specific cell population is required for serial transplantation in animal models. However, a specific signature of cell surface proteins that can identify cancer stem cells has not been developed for many solid tumors. In this review, we summarize a new technique for identifying and quantifying cancer stem cells in situ, which could be a valuable technique for evaluating the effects of therapies on this cell population. Finally, we conclude by discussing several preclinical treatment strategies that either reprogram cancer stem cells or cause them to be specifically attacked by immune cells. In summary, therapeutic and diagnostic methodologies that can attack and quantify cancer stem cells, respectively, will be valuable tools for eradicating cancer.

元の言語英語
ページ(範囲)232-237
ページ数6
ジャーナルJapanese journal of clinical oncology
49
発行部数3
DOI
出版物ステータス出版済み - 3 1 2019
外部発表Yes

    フィンガープリント

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

これを引用